EVOQTrading & Distributors
Evoq Remedies Ltd — Cash Flow Statement
₹2.30
+0.80%
Evoq Remedies Ltd Cash Flow Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Free Cash Flow | -14.88 Cr | 5.31 Cr | -4.36 Cr | -26.43 Cr | — |
| Repayment Of Debt | -4.24 Cr | -5.34 Cr | — | — | — |
| Issuance Of Debt | 0.00 | 0.00 | 1.42 Cr | 8.16 Cr | — |
| Issuance Of Capital Stock | 19.21 Cr | 0.00 | 0.00 | 21.33 Cr | — |
| Capital Expenditure | -0.26 Cr | -0.01 Cr | -0.01 Cr | — | — |
| End Cash Position | 0.21 Cr | 0.12 Cr | 0.15 Cr | 3.09 Cr | — |
| Beginning Cash Position | 0.12 Cr | 0.15 Cr | 3.09 Cr | 0.03 Cr | — |
| Changes In Cash | 0.09 Cr | -0.03 Cr | -2.94 Cr | 3.06 Cr | — |
| Financing Cash Flow | 14.97 Cr | -5.34 Cr | 1.42 Cr | 29.49 Cr | — |
| Net Common Stock Issuance | 19.21 Cr | 0.00 | 0.00 | 21.33 Cr | — |
| Common Stock Issuance | 19.21 Cr | 0.00 | 0.00 | 21.33 Cr | — |
| Net Issuance Payments Of Debt | -4.24 Cr | -5.34 Cr | 1.42 Cr | 8.16 Cr | — |
| Net Short Term Debt Issuance | -4.24 Cr | -5.34 Cr | 1.42 Cr | 8.16 Cr | — |
| Short Term Debt Payments | -4.24 Cr | -5.34 Cr | — | — | — |
| Net Long Term Debt Issuance | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Long Term Debt Issuance | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Investing Cash Flow | -0.26 Cr | -0.01 Cr | -0.01 Cr | 0.00 | — |
| Net Investment Purchase And Sale | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Purchase Of Investment | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net Business Purchase And Sale | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Purchase Of Business | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net PPE Purchase And Sale | -0.26 Cr | -0.01 Cr | -0.01 Cr | 0.00 | — |
| Sale Of PPE | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Purchase Of PPE | -0.26 Cr | -0.01 Cr | -0.01 Cr | 0.00 | — |
| Operating Cash Flow | -14.62 Cr | 5.32 Cr | -4.35 Cr | -26.43 Cr | — |
| Taxes Refund Paid | -0.04 Cr | -0.16 Cr | -0.67 Cr | -0.37 Cr | — |
| Interest Paid Cfo | 0.00 | 0.00 | -13000.00 | -46000.00 | — |
| Dividend Paid Cfo | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Change In Working Capital | -14.76 Cr | 4.86 Cr | -5.97 Cr | -27.52 Cr | — |
| Change In Other Current Liabilities | -2.04 Cr | 3.08 Cr | -0.22 Cr | 0.23 Cr | — |
| Change In Other Current Assets | -10.50 Cr | 7.21 Cr | -7.30 Cr | -0.16 Cr | — |
| Change In Payable | 0.21 Cr | 3.82 Cr | -1.75 Cr | -5.57 Cr | — |
| Change In Inventory | 0.91 Cr | -1.09 Cr | -1.25 Cr | -0.63 Cr | — |
| Change In Receivables | -3.25 Cr | -8.19 Cr | 4.05 Cr | -21.43 Cr | — |
| Deferred Tax | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Depreciation And Amortization | 0.05 Cr | 73000.00 | 39000.00 | 0.00 | — |
| Depreciation | 0.05 Cr | 73000.00 | 39000.00 | — | — |
| Gain Loss On Sale Of PPE | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net Income From Continuing Operations | 0.13 Cr | 0.61 Cr | 2.28 Cr | 1.46 Cr | — |
| Repurchase Of Capital Stock | — | — | 0.00 | 0.00 | 0.00 |
| Common Stock Payments | — | — | 0.00 | 0.00 | 0.00 |
| Short Term Debt Issuance | — | — | 1.42 Cr | 8.16 Cr | 0.00 |
| Other Non Cash Items | — | — | 13000.00 | 46000.00 | 1826.00 |
| Sale Of Investment | — | — | — | 0.00 | 0.00 |
| Other Cash Adjustment Outside Changein Cash | — | — | — | — | 1.00 |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Evoq Remedies Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.